No products in the cart.
Enveda Raises $311M for Nature-Derived AI Drug Trials
Enveda's recent $311 million funding round marks a pivotal moment in biotech, emphasizing…
Enveda's recent $311 million funding round marks a pivotal moment in biotech, emphasizing…
The FDA's recent approval of Daraxonrasib marks a significant advancement in treatment…
Lupin's acquisition of Kaveri Therapeutics marks a significant shift in oncology research…
Pharmaceutical giants Lilly and Novo Nordisk are expanding their obesity drug markets…
Welcome, Login to your account.
Welcome, Create your new account
A password will be e-mailed to you.